Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages:: Implications for the pathogenesis of cutaneous leishmaniasis

被引:75
作者
Qi, H
Ji, JX
Wanasen, N
Soong, L
机构
[1] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
关键词
D O I
10.1128/IAI.72.2.988-995.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During Leishmania major infection in mice, gamma interferon (IFN-gamma) plays an essential role in controlling parasite growth and disease progression. In studies designed to ascertain the role of IFN-gamma in Leishmania amazonensis infection, we were surprised to find that IFN-gamma could promote L. amazonensis amastigote replication in macrophages (MPhis), although it activated MPhis to kill promastigotes. The replication-promoting effect of IFN-gamma on amastigotes was independent of the source and genetic background of MPhis, was apparently not affected by surface opsonization of amastigotes, was not mediated by interleukin-10 or transforming growth factor beta, and was observed at different temperatures. Consistent with the different fates of promastigotes and amastigotes in IFN-gamma-stimulated MPhis L. amazonensis-specific Th1 transfer helped recipient mice control L. amazonensis infection established by promastigotes but not L. amazonensis infection established by amastigotes. On the other hand, IFN-gamma could stimulate MPhis to limit amastigote replication when it was coupled with lipopolysaccharides but not when it was coupled with tumor necrosis factor alpha. Thus, IFN-gamma may play a bidirectional role at the level of parasite-MPhi interactions; when it is optimally coupled with other factors, it has a protective effect against infection, and in the absence of such synergy it promotes amastigote growth. These results reveal a quite unexpected aspect of the L. amazonensis parasite and have important implications for understanding the pathogenesis of the disease and for developing vaccines and immunotherapies.
引用
收藏
页码:988 / 995
页数:8
相关论文
共 56 条
[11]  
3.0.CO
[12]  
2-4
[13]   Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages [J].
Courret, N ;
Frehel, C ;
Prina, E ;
Lang, T ;
Antoine, JC .
PARASITOLOGY, 2001, 122 :263-279
[14]   Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8(+) T cells do not mediate a protective immune response [J].
Erb, K ;
Blank, C ;
Ritter, U ;
Bluethmann, H ;
Moll, H .
IMMUNOBIOLOGY, 1996, 195 (02) :243-260
[15]   Molecular biology of nitric oxide synthases [J].
Geller, DA ;
Billiar, TR .
CANCER AND METASTASIS REVIEWS, 1998, 17 (01) :7-23
[16]  
GREEN SJ, 1990, J IMMUNOL, V145, P4290
[17]  
GREEN SJ, 1990, J IMMUNOL, V144, P278
[18]   In vitro maintenance of Leishmania amastigotes directly from lesions: Advantages and limitations [J].
Hodgkinson, VH ;
Soong, L .
JOURNAL OF PARASITOLOGY, 1997, 83 (05) :953-956
[19]  
HOLADAY BJ, 1991, J IMMUNOL, V147, P1653
[20]   Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana [J].
Ilg, T .
EMBO JOURNAL, 2000, 19 (09) :1953-1962